Cardiogenic Pulmonary Oedema

Author: Victoria L Henson / Editor: Jason M Kendall / Reviewer: Louise Burrows, Peter Kilgour, Debkumar Chowdhury / Codes: / Published: 22/03/2021 / Reviewed: 30/05/2025

This module discusses cardiogenic pulmonary oedema, covering its causes, clinical assessment, management and long-term outcomes. It guides Emergency Medicine (EM) clinicians in assessing breathless patients and outlines appropriate investigations and treatments.

After completing this session you will be able to:

  • Define cardiogenic pulmonary oedema
  • Describe the pathophysiology of cardiogenic pulmonary oedema
  • Clinically assess a breathless patient and recognise cardiogenic pulmonary oedema
  • Investigate and treat cardiogenic pulmonary oedema within the emergency department (ED)
  • Describe the long-term outcome for this patient group

References

  1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: : Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368. Erratum in: Eur Heart J. 2021 Dec 21;42(48):4901.
  2. Chaudhry MM. et al. Correlation between Elevated D-Dimer and BNP Levels in Various Clinical Diagnoses. Journal of Cardiac Failure, Volume 15, Issue 6, S35, 2009.
  3. Rippey J. Lung ultrasound: Pulmonary oedema. Life in the Fast Lane, 2022.
  4. McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195. Erratum in: Eur Heart J. 2024 Jan 1;45(1):53.
  5. A Gray, S Goodacre, D E Newby, M Masson et al. Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema. The New England Journal of Medicine. July 10 2008. Vol 359, iss 2: pg 142.
  6. O’Driscoll BR, Howard LS, Earis J on behalf of the BTS Emergency Oxygen Guideline Development Group, et al British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings BMJ Open Respiratory Research 2017;4:e000170. doi: 10.1136/bmjresp-2016-000170.
  7. F M R Vital, H Saconato, M T Ladeira, A Sen, et al. Noninvasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema (Review).  Cochrane Database of Systemic Reviews 2008, Issue 3.Art.No.: CD005351.DOI: 10.1002/14651858.CD005351.pub2.
  8. A Mattu, J P Martinez, D S Kelly. Modern Management of Cardiogenic Pulmonary Edema. Emergency Medicine Clinics of North America 23(2005) 1105-1125.
  9. D Feldman, D M Menachemi, W T Abraham, R K Wexler. Management strategies for stage D patients with acute heart failure. Clinical Cardiology 31, 7, 297-301 (2008).
  10. G Cotter, E Metzkor, Z Faigenerg, R Miller, A Simovitz et al. Randomised trial of high dose isosorbide dinitrate plus low dose furosemide versus high dose furosemide plus low dose isosorbide dinitrate in severe pulmonary oedema. The Lancet. Vol 351, February 7th 1998 page389-393.
  11. M Metra, J R Teerlink, A A Voors, G M Felker, O Milo-Cotter et al. Vasodilators in the treatment of acute heart failure: what we know, what we dont. Heart failure Reviews. DOI 10.1007/s10741-008-9127-5.

Leave a Reply